A carregar...
Cushing’s disease: Does low-dose pasireotide offer a comparable efficacy and safety to high-dose?
Whilst literature is expanding on pasireotide use in the management of Cushing’s disease (CD), there is still currently much unknown about long-term and low-dose pasireotide use in CD. We present a 60-year-old female with residual CD after transphenoidal surgery (TSS), being successfully managed wit...
Na minha lista:
| Publicado no: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Bioscientifica Ltd
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7923187/ https://ncbi.nlm.nih.gov/pubmed/33865235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-20-0206 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|